NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Crosses Above 50-Day Moving Average of $0.00

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.10. NovaBay Pharmaceuticals shares last traded at $0.09, with a volume of 1,461,449 shares changing hands.

NovaBay Pharmaceuticals Price Performance

The stock has a market cap of $399,529.00, a price-to-earnings ratio of -0.01 and a beta of 2.82.

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) last posted its earnings results on Tuesday, March 26th. The biopharmaceutical company reported ($0.95) EPS for the quarter. The firm had revenue of $3.73 million during the quarter. NovaBay Pharmaceuticals had a negative net margin of 79.70% and a negative return on equity of 146.20%. As a group, equities analysts expect that NovaBay Pharmaceuticals, Inc. will post -2.54 EPS for the current year.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.